The largest database of trusted experimental protocols

Shcoo2

Manufactured by Merck Group

SHCOO2 is a laboratory equipment product designed for scientific research and analysis. It serves as a core functional tool for various experimental and analytical procedures. The product's specifications and technical details are maintained by the Merck Group, the manufacturer.

Automatically generated - may contain errors

3 protocols using shcoo2

1

Lentiviral Transduction of NB4 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
pLKO.1 lentiviral vectors expressing small hairpin (sh)RNAs targeting WIPI-1, WIPI-2, PI3KC3 and BECN1 or a non-targeting shRNA control (SHCOO2) were purchased from Sigma-Aldrich. A lentiviral vector expressing EGFP-Cherry-LC3 was provided by Dr. MS Soengas. Lentiviral production and transduction of NB4 cells was done as described.51 (link) EGFP-Cherry-LC3 NB4 cells with WIPI-1, WIPI-2 and BECN1 knockdown were generated by serial transduction with both lentiviral vectors described above. Transduced cell populations were selected for 4 days using 1.5 μg/ml puromycin. qPCR was performed to evaluate knockdown efficiency in NB4 WIPI-1, WIPI-2 and BECN1 knockdown cells, whereas western blotting was employed for demonstration for beclin 1 inhibition. To generate PU.1-inducible cells, the pCl10A1 retroviral packaging plasmid and the pBabe-PUER-puro (kindly provided by Dr. H Yoshida) were co-transfected into 293T cells. Cell culture medium was removed after 1 day and cells were incubated for 2 min with PBS/15% glycerol. PBS/15% glycerol was replaced by fresh medium. Viral supernatants were harvested 48 h later. NB4 cells were transduced for 24 h in the presence of 8 μg/ml polybrene. Transduced NB4 cell populations were selected with 1.5 μg/ml puromycin for 4 days.
+ Open protocol
+ Expand
2

Silencing ANGPTL3 in Immortalized Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Liver IHHs immortalized by SV40 large T-Antigen (IHH, ATCC® PTA-5565™) were transduced with MISSION™ shRNA (small hairpin RNA) Lentiviral Vector particles (TRCN0000242782, Sigma Aldrich) targeting ANGPTL3 (NM_014495.2) or with non-target shRNA (SHCOO2, Sigma Aldrich) [MOI (multiplicity of infection) 1]. Positive cells were selected against 5 μg/ml puromycin for 12 days. The transduction was repeated once after the first selection. Cells were cultured in Williams medium E (Gibco by Life Technologies, 22551-022) with added 10% (v/v) FBS and glutamine 0.2 mg/ml and incubated +37 °C. FBS was removed during experiments and total protein from cell lysates was used to normalize the data. Cells were washed with PBS (pH 7.4) and lysed in RIPA buffer. Protein concentration was measured with Bradford protein assay (Bio-Rad). Following compounds were used: insulin (bovine, Sigma-Aldrich), Wortmannin (Sigma-Aldrich), Akt1/2 inhibitor (Sigma-Aldrich), rosiglitazone (Cayman Chemical) and GW9662 (Sigma-Aldrich).
+ Open protocol
+ Expand
3

Lentiviral Knockdown of DAXX and Micronuclei Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
For virus infection, 6 × 10 5 cells were seeded in 6-well plates the day before. pLKO.1 lentiviral vectors expressing small hairpin (sh) RNAs targeting DAXX (Sh-DAXX_H2410: and Sh-DAXX_2503) or a nontargeting shRNA control (SHCOO2) were purchased from Sigma-Aldrich. Lentiviral production and transduction were done as described in Tschan et al. (2003) . Transduced cells were selected by puromycin treatment (1.5 µg/mL, Invitrogen). For micronuclei counting, cells were seeded in 24-well plates on coverslips coated with FBS, 1 × 10 4 cells per well. Cells were fixed with 4% paraformaldehyde for 30 min at room temperature. DAPI was used to stain nuclei. Micronuclei were counted under a fluorescent microscope (Axiophot2, Zeiss).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!